Found: 99
Select item for more details and to access through your institution.
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 8, p. 1294, doi. 10.1093/jnci/djae081
- By:
- Publication type:
- Article
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 20, p. 1961, doi. 10.1001/jama.2023.20181
- By:
- Publication type:
- Article
Head and neck MRI-based T stage and [<sup>18</sup>F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
- Published in:
- European Radiology, 2023, v. 33, n. 11, p. 7952, doi. 10.1007/s00330-023-09815-6
- By:
- Publication type:
- Article
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40402-x
- By:
- Publication type:
- Article
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 8, p. 1, doi. 10.1038/s41419-023-06028-z
- By:
- Publication type:
- Article
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
- Published in:
- European Radiology, 2023, v. 33, n. 5, p. 3682, doi. 10.1007/s00330-023-09431-4
- By:
- Publication type:
- Article
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10494-7
- By:
- Publication type:
- Article
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
- Published in:
- European Radiology, 2022, v. 32, n. 11, p. 7722, doi. 10.1007/s00330-022-08814-3
- By:
- Publication type:
- Article
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
M1 stage subdivisions based on 18 F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221118785
- By:
- Publication type:
- Article
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 8, p. 2972, doi. 10.1007/s00259-022-05793-x
- By:
- Publication type:
- Article
Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
- Published in:
- Head & Neck, 2022, v. 44, n. 5, p. 1057, doi. 10.1002/hed.26999
- By:
- Publication type:
- Article
Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e220173, doi. 10.1001/jamanetworkopen.2022.0173
- By:
- Publication type:
- Article
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2022, v. 29, p. 1, doi. 10.1177/10732748221124868
- By:
- Publication type:
- Article
Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus DNA.
- Published in:
- Head & Neck, 2022, v. 44, n. 1, p. 34, doi. 10.1002/hed.26897
- By:
- Publication type:
- Article
Management of first‐line palliative chemotherapy for post‐treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non‐gemcitabine plus cisplatin chemotherapy.
- Published in:
- Head & Neck, 2022, v. 44, n. 1, p. 113, doi. 10.1002/hed.26899
- By:
- Publication type:
- Article
Correction to: Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2138470, doi. 10.1001/jamanetworkopen.2021.38470
- By:
- Publication type:
- Article
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-09063-1
- By:
- Publication type:
- Article
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Alpha-fetoprotein–producing recurrent nasopharyngeal carcinoma: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5371, doi. 10.1007/s00520-021-06128-6
- By:
- Publication type:
- Article
Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.627935
- By:
- Publication type:
- Article
RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis.
- Published in:
- Advanced Science, 2021, v. 8, n. 16, p. 1, doi. 10.1002/advs.202004852
- By:
- Publication type:
- Article
RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis.
- Published in:
- Advanced Science, 2021, v. 8, n. 16, p. 1, doi. 10.1002/advs.202004852
- By:
- Publication type:
- Article
Efficacy of Transnasal Endoscopic Fine‐Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma.
- Published in:
- Laryngoscope, 2021, v. 131, n. 8, p. 1798, doi. 10.1002/lary.29433
- By:
- Publication type:
- Article
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21043-4
- By:
- Publication type:
- Article
Alpha-fetoprotein–producing recurrent nasopharyngeal carcinoma: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2021, v. 9, p. 1, doi. 10.1177/2050313X211057704
- By:
- Publication type:
- Article
Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [<sup>18</sup>F]‐fluorodeoxyglucose positron emission tomography
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8852, doi. 10.1002/cam4.3500
- By:
- Publication type:
- Article
Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.539321
- By:
- Publication type:
- Article
Longitudinal Trend of Health-Related Quality of Life During Concurrent Chemoradiotherapy and Survival in Patients With Stage II–IVb Nasopharyngeal Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.579292
- By:
- Publication type:
- Article
Hypoxia Induces Mitochondrial Defect That Promotes T Cell Exhaustion in Tumor Microenvironment Through MYC-Regulated Pathways.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01906
- By:
- Publication type:
- Article
Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01295
- By:
- Publication type:
- Article
Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation.
- Published in:
- Oncogenesis, 2020, v. 9, n. 7, p. 1, doi. 10.1038/s41389-020-00248-0
- By:
- Publication type:
- Article
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928214
- By:
- Publication type:
- Article
Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1661, doi. 10.1002/cam4.2841
- By:
- Publication type:
- Article
Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00255
- By:
- Publication type:
- Article
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Development of a Nomogram to Predict Post-Radiation Necrosis in Nasopharyngeal Carcinoma Patients: A Large-Scale Cohort Study [Corrigendum].
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 1371, doi. 10.2147/CMAR.S246689
- By:
- Publication type:
- Article
The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study.
- Published in:
- Cancer Communications, 2020, v. 40, n. 1, p. 32, doi. 10.1002/cac2.12004
- By:
- Publication type:
- Article
Combining pretreatment plasma Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6841, doi. 10.1002/cam4.2481
- By:
- Publication type:
- Article
Relationship of circulating tumor cells and Epstein–Barr virus DNA to progression‐free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 10, p. 2873, doi. 10.1002/ijc.32380
- By:
- Publication type:
- Article
Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1259, doi. 10.4143/crt.2018.652
- By:
- Publication type:
- Article
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1449, doi. 10.4143/crt.2018.688
- By:
- Publication type:
- Article
Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Maximal standard uptake values of <sup>18</sup>F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study.
- Published in:
- Drug Design, Development & Therapy, 2019, v. 13, p. 3207, doi. 10.2147/DDDT.S215190
- By:
- Publication type:
- Article